CONFERENCES
Scientific Sessions
PHA Canada is pleased to invite Canada’s health care providers to our 7th National Pulmonary Hypertension Scientific Sessions. Join us in Vancouver on September 25, 2026, for a full day of research and practice updates and engaging community discussion.
​
“A good mix of clinical and basic science. Nice to hear Canadian science. Great invited speakers.”
event participant, 2025
.jpg)
Audience​​
​The Pulmonary Hypertension Scientific Sessions welcomes health care providers who manage patients with pulmonary hypertension, including (but not limited to) cardiologists, respirologists, nurse practitioners, pharmacists, physician assistants, medical students and residents, graduate students, nurses, clinical fellows, and researchers.​
Details​
September 25, 2026, all day
​
In person at the Sheraton Vancouver Airport Hotel:
-
Physicians: $375.00
-
Allied health professionals and trainees: $225.00
-
There will be a separately ticketed opening dinner and educational session the evening of September 24: $50
-
See the Travel and Accommodations page for hotel and transit details
​
Virtually via Zoom: $75.00
Registration​
​
Registration will open on May 1, 2026.
Program​
​
“High yield content, with each talk short and focused” – event participant, 2025
​​
Come prepared for a full, intense day of learning! The program features two keynote speakers and ten additional 30-minute sessions on a wide variety of pulmonary hypertension-related topics.
​
The program is co-developed by the Pulmonary Hypertension Association of Canada and the Canadian Thoracic Society and is planned to achieve scientific integrity, objectivity, and balance.
​
In conjunction with PHA Canada’s 2026 Pulmonary Hypertension Community Conference.
Overall objectives
-
Ensure the timely and accurate diagnosis of pulmonary hypertension (PH) across Canada
-
Support health care providers in ensuring a comprehensive assessment of all PH patients
-
Support health care providers in ensuring the most effective treatment approach for all PH patients
-
Facilitate the implementation of standards of excellence for pulmonary hypertension care in Canada; and
-
Support national pulmonary hypertension medical projects like the National PH Registry and Canadian PH Clinical Trials Network.